This company has shut down. Ultivue is no longer operating — its last tracked round was a Venture - Series Unknown in 2024.
Explore the Startup GraveyardUltivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.
Ultivue has raised $3.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.
Ultivue's investors include ARCH Venture Partners, Ally Bridge Group, 6 Dimensions Capital, Tao Capital Partners, Yonghua Capital.
Ultivue is headquartered in Cambridge, United States.
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.
Ultivue is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ultivue — Funding & Investors." VCBacked, July 25, 2024, https://www.vcbacked.co/company/ultivue. Accessed September 20, 2026.
VCBacked. (2024). Ultivue — Funding & Investors. Retrieved September 20, 2026, from https://www.vcbacked.co/company/ultivue
{{cite web |title=Ultivue — Funding & Investors |url=https://www.vcbacked.co/company/ultivue |website=VCBacked |access-date=September 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated